# A Trial of Cilostazol in Patients With Mild Cognitive Impairment (COMCID)

> **NCT02491268** · PHASE2 · COMPLETED · sponsor: **National Cerebral and Cardiovascular Center, Japan** · enrollment: 166 (actual)

## Conditions studied

- Mild Cognitive Impairment

## Interventions

- **DRUG:** Cilostazol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02491268
- **Lead sponsor:** National Cerebral and Cardiovascular Center, Japan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-01
- **Primary completion:** 2020-08-14
- **Final completion:** 2020-12-01
- **Target enrollment:** 166 (ACTUAL)
- **Last updated:** 2020-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02491268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02491268, "A Trial of Cilostazol in Patients With Mild Cognitive Impairment (COMCID)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02491268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*